| First Author | Rahrmann EP | Year | 2022 |
| Journal | Nat Genet | Volume | 54 |
| Issue | 12 | Pages | 1827-1838 |
| PubMed ID | 36175792 | Mgi Jnum | J:333728 |
| Mgi Id | MGI:7440123 | Doi | 10.1038/s41588-022-01182-0 |
| Citation | Rahrmann EP, et al. (2022) The NALCN channel regulates metastasis and nonmalignant cell dissemination. Nat Genet 54(12):1827-1838 |
| abstractText | We identify the sodium leak channel non-selective protein (NALCN) as a key regulator of cancer metastasis and nonmalignant cell dissemination. Among 10,022 human cancers, NALCN loss-of-function mutations were enriched in gastric and colorectal cancers. Deletion of Nalcn from gastric, intestinal or pancreatic adenocarcinomas in mice did not alter tumor incidence, but markedly increased the number of circulating tumor cells (CTCs) and metastases. Treatment of these mice with gadolinium-a NALCN channel blocker-similarly increased CTCs and metastases. Deletion of Nalcn from mice that lacked oncogenic mutations and never developed cancer caused shedding of epithelial cells into the blood at levels equivalent to those seen in tumor-bearing animals. These cells trafficked to distant organs to form normal structures including lung epithelium, and kidney glomeruli and tubules. Thus, NALCN regulates cell shedding from solid tissues independent of cancer, divorcing this process from tumorigenesis and unmasking a potential new target for antimetastatic therapies. |
